Windlas Biotech Faces Evaluation Shift Amidst Evolving Market Dynamics and Financial Performance

Sep 04 2025 08:22 AM IST
share
Share Via
Windlas Biotech has experienced a recent evaluation adjustment, reflecting changes in its technical indicators. The company reported strong quarterly financial results for Q1 FY25-26, with net sales of Rs 210.09 crore and a low debt-to-equity ratio. Despite modest operating profit growth, the stock has shown consistent returns over the past three years.
Windlas Biotech, a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently undergone an adjustment in evaluation, reflecting changes in its technical indicators. The stock's technical trend has shifted from a sideways movement to a mildly bearish stance, as indicated by various metrics.

In terms of performance, Windlas Biotech reported a notable quarterly financial performance for Q1 FY25-26, with net sales reaching Rs 210.09 crore and a PBDIT of Rs 26.53 crore. The company has maintained a low debt-to-equity ratio, which stands at an average of 0 times, suggesting a conservative approach to leverage. Despite a positive return of 17.10% over the past year, the stock's operating profit growth has been modest at an annual rate of 15.08% over the last five years.

The stock is currently trading at a premium compared to its peers' average historical valuations, with a price-to-book value of 4.1. The return on equity (ROE) is reported at 12.1, indicating a fair valuation. While the stock has shown consistent returns over the last three years, the recent evaluation adjustment highlights the evolving market dynamics surrounding Windlas Biotech.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News